ݺߣ

ݺߣShare a Scribd company logo

Medical Presentation Template

•
•
Improve Presentation
Improve Presentation

A comprehensive medical presentation template covering healthcare related topics and most popular human organs. Medical icons are included as a bonus. LINK -> https://www.improvepresentation.com/presentation-templates/medical-presentation-template

1 of 47
Downloaded 84 times
Medical Presentation Template Deck Multiline,  sophisticated   subtitle  text Q.  RALL   SYDNEY,  14  FEBRUARY  2015
Agenda C L I C K   T O   A D D   S U B T I T L E 1 2 3 4 5 Introduction Anatomical knowledge behind the discovery Our method compared to others available Pros and cons of using the newest drug Q&A session
Multiline  chapter   subtitle  text Part One: Introduction
Contact Information B E   S U R E   T O   C O N TA C T   U S   I N   C A S E   O F   A N Y   D O U B T S I. Q. Rall i.q.rall@yahoo.com +1 415 599 2671 228 West 47th Street New York City NY 10036
And,  if  we  know  how  to  do  this,  why  isn’t  everybody   doing  it  already? How to prevent the disease?
Q&A  session Any questions?
Disease Causes FA C T O R S   T H AT   L E A D   T O   I N C R E A S E D   S U S C E P T I B I L I T Y Diabetes type A First cause of the disease Second cause of the disease Third cause of the disease Fourth cause of the disease
Drug characteristics L O R E M   I P S U M   D O L O R   S I T   A M E T ONLY  NATURAL   COMPONENTS IMMEDIATE   ACTION SUITABLE   FOR  CHILDREN LONG  LASTING   EFFECTS
Disease Symptoms FA C T O R S   T H AT   L E A D   T O   I N C R E A S E D   S U S C E P T I B I L I T Y Diabetes type A Diabetes type A First cause of the disease Second cause of the disease Third cause of the disease Fourth cause of the disease
Summary L O R E M   I P S U M   D O L O R   S I T   A M E T Summary bullet Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit. Summary bullet Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit. Summary bullet Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit. Summary bullet Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit.
Milestones M A J O R   E V E N T S   I N   L I F E T I M E   O F   T H E   P R O J E C T Birth of Initial Idea JANUARY  2011 Milestone Name APRIL  2013 Milestone Name DECEMBER  2013 Milestone Name NOVEMBER  2014 Product Ready for Market FEBRUARY  2015 Lorem  ipsum   dolor  sit  amet,   consectetur   adipiscing  elit. Lorem  ipsum   dolor  sit  amet,   consectetur   adipiscing  elit. Lorem  ipsum   dolor  sit  amet,   consectetur   adipiscing  elit. Lorem  ipsum   dolor  sit  amet,   consectetur   adipiscing  elit. Lorem  ipsum   dolor  sit  amet,   consectetur   adipiscing  elit.
The Procedure S T E P -­‐ B Y-­‐ S T E P   I N S T R U C T I O N S I II III IV Lorem  ipsum   dolor  sit  amet,   consectetur   adipiscing  elit. Lorem  ipsum   dolor  sit  amet,   consectetur   adipiscing  elit. Lorem  ipsum   dolor  sit  amet,   consectetur   adipiscing  elit. Lorem  ipsum   dolor  sit  amet,   consectetur   adipiscing  elit.
Disease phases First phase DescripZon  of  the  phase.  Lorem  ipsum  dolor  sit  amet.I Second phase DescripZon  of  the  phase.  Lorem  ipsum  dolor  sit  amet.II Third phase DescripZon  of  the  phase.  Lorem  ipsum  dolor  sit  amet.III Fourth phase DescripZon  of  the  phase.  Lorem  ipsum  dolor  sit  amet.IV Fifth phase DescripZon  of  the  phase.  Lorem  ipsum  dolor  sit  amet.V
Drug specification L O R E M   I P S U M   D O L O R E S 15ML   VOLUME 30MG/S   FLOW  RATE 0.20MM   PARTICLE  SIZE 30MIN   ONSET  OF  ACTION
Subtitle  line The Team Behind the Discovery John Doe Head  of  the   department Jane Doe Chief  of   research John Doe Researcher Lab  worker John Doe
“This great idea has completely changed my life. I highly recommend this new approach.” ANDY “This great idea has completely changed my life. I highly recommend this new approach.” REBECCA “This great idea has completely changed my life. I highly recommend this new approach.” JOHN
Drug Taking Instructions I M P O R TA N T   P O I N T E R S Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit. Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit. Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit. Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit. Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit.
Categories C L I C K   T O   A D D   S U B T I T L E Category A Category B Category C Lorem  ipsum  dolor  sit  amet,  consectetur     adipiscing  elit,  sed  do  eiusmod  tempor     incididunt  ut  labore  et  dolore  magna  aliqua. Lorem  ipsum  dolor  sit  amet,  consectetur     adipiscing  elit,  sed  do  eiusmod  tempor     incididunt  ut  labore  et  dolore  magna  aliqua. Lorem  ipsum  dolor  sit  amet,  consectetur     adipiscing  elit,  sed  do  eiusmod  tempor     incididunt  ut  labore  et  dolore  magna  aliqua.
Subtitle  line Drugs comparison Drug A Drug B SALICYLIC  ACID IBUPROFENACTIVE  INGREDIENT RISK  OF  COMPLICATIONS16% 40% AMOUNT 200MG325MG
Method Comparison CRITERION  ONE CRITERION  ONE CRITERION  ONE CRITERION  ONE CRITERION  ONE Method A Method B Method C
Prescription Drug Analysis PROSCONS Sed  do  eiusmod  tempor  incididunt Lorem  ipsum  dolor  sit  amet Consectetur  adipiscing  elit Sed  do  eiusmod  tempor  incididunt Ut  labore  et  dolore  magna  aliqua Ut  enim Consectetur  adipiscing  elit Lorem  ipsum  dolor  sit  amet Ut  labore  et  dolore  magna  aliqua Ut  enim
Summary of Expenses L O R E M   I P S U M   D O L O R E S TESTS APPOINTMENTS MISCELLANEOUS TEA  AND  COFFEE TOTAL 2000  $ 7000  $ 2500  $ 500  $ 12  000  $
Left Side of Bony Pelvis A S   D E S C R I B E D   I N   P R O F E S S I O N A L   L I T E R AT U R E Lorem  ipsum  dolor  sit  amet,  consectetur     adipiscing  elit,  sed  do  eiusmod  tempor     incididunt  ut  labore  et  dolore  magna   aliqua.  Ut  enim.  Lorem  ipsum  dolor  sit     amet,  consectetur  adipiscing  elit.
Left Side of Bony Pelvis - main issues A S   D E S C R I B E D   I N   P R O F E S S I O N A L   L I T E R AT U R E Top corner fraction Lorem  ipsum  dolor  sit  amet,  consectetur     adipiscing  elit,  sed  do  eiusmod  tempor     incididunt  ut  labore  et  dolore  magna  aliqua.     Ut  enim. Bottom end something Lorem  ipsum  dolor  sit  amet,  consectetur     adipiscing  elit,  sed  do  eiusmod  tempor     incididunt  ut  labore  et  dolore  magna  aliqua.     Ut  enim. 1 2 2 1
Additional  description  text   concerning  the  problem Challenges we’re facing Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit,   sed  do  eiusmod  tempor   incididunt  ut  labore  et   dolore  magna  aliqua. 1. Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit,   sed  do  eiusmod  tempor   incididunt  ut  labore  et   dolore  magna  aliqua. 2. Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit,   sed  do  eiusmod  tempor   incididunt  ut  labore  et   dolore  magna  aliqua. 3.
Click to add Title C L I C K   T O   A D D   S U B T I T L E The art of medicine consists in amusing the patient while nature cures the disease. —    VOLTAIRE
Click to add Title C L I C K   T O   A D D   S U B T I T L E Disease name —  SOURCE,  YEAR,  ADDITIONAL  INFO Dictionary definition of this particular disease. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem  ipsum  dolor  sit  amet,  consec-­‐  tetur  adipiscingelit,  seddo  eiusmod  tempor  incididuntutlabore. million people with diabetes 381
Multiple Pie Charts L O R E M   I P S U M   D O L O R E S LOREM  IPSUM   DOLOR  SIT   AMET 84% 16% LOREM  IPSUM   DOLOR  SIT   AMET60% 40% LOREM  IPSUM   DOLOR  SIT   AMET 84% 16% LOREM  IPSUM   DOLOR  SIT   AMET60% 40% LOREM  IPSUM   DOLOR  SIT   AMET 84% 16% LOREM  IPSUM   DOLOR  SIT   AMET60% 40% PATIENTS  WITH    FOOT  ULCER PATIENTS  WITH  HEALTHY  FEET
Click to add Title C L I C K   T O   A D D   S U B T I T L E over of  world’s  population   is  predicted  to  be  sick   by  2020 45%
Drug Reception C O R R E L AT I O N   B E T W E E N   D R U G   D O S A G E   A N D   S E V E R A L   I N D I C AT O R S           SOURCE:  INTERNATIONAL  MEDICAL  JOURNAL  5/12 DRUG  DOSE CHEMICAL  ACTIVITIY 1 2 3 Second indicator 1 2 First indicator 3 Third indicator
Drug Reception C O R R E L AT I O N   B E T W E E N   D R U G   D O S A G E   A N D   I T S   C H E M I C A L   A C T I V I T Y           DRUG  DOSE CHEMICAL  ACTIVITIY Observation Lorem  ipsum  dolor  sit  amet,  consectetur. Observation Lorem  ipsum  dolor  sit  amet,  consectetur. Observation Lorem  ipsum  dolor  sit  amet,  consectetur.
Disease Stadia L O R E M   I P S U M   D O L O R E S Lorem  ipsum  dolor           sit  amet,  consectetur   adipiscing  elit,  sed   do  eiusmod  tempor   inci-­‐  didunt  ut  labore   et  dolore  magna   aliqua.  Ut  enim  ad   minim  veniam,  quis   nostrud First Stadium Second Stadium Third Stadium Fourth Stadium Lorem  ipsum  dolor           sit  amet,  consectetur   adipiscing  elit,  sed   do  eiusmod  tempor   inci-­‐  didunt  ut  labore   et  dolore  magna   aliqua.  Ut  enim  ad   minim  veniam,  quis   nostrud Lorem  ipsum  dolor           sit  amet,  consectetur   adipiscing  elit,  sed   do  eiusmod  tempor   inci-­‐  didunt  ut  labore   et  dolore  magna   aliqua.  Ut  enim  ad   minim  veniam,  quis   nostrud Lorem  ipsum  dolor           sit  amet,  consectetur   adipiscing  elit,  sed   do  eiusmod  tempor   inci-­‐  didunt  ut  labore   et  dolore  magna   aliqua.  Ut  enim  ad   minim  veniam,  quis   nostrud DAY    0 AFTER  A  WEEK FIRST  MONTH AFTER  A  YEAR
Sources  of  financing Finances 44% 40% 16% SOURCE  A SOURCE  B SOURCE  C LOREM  IPSUM  DOLOR  SIT  AMET,   CONSECTETUR  ADIPISCING  ELIT LOREM  IPSUM  DOLOR  SIT  AMET,   CONSECTETUR  ADIPISCING  ELIT LOREM  IPSUM  DOLOR  SIT  AMET,   CONSECTETUR  ADIPISCING  ELIT
Officially reported cases L O R E M   I P S U M   D O L O R E S 0 125 250 375 500 1985 1990 1995 2000 2005 2010 2015 110 199 280 395 297 378 460 SOURCE:  INTERNATIONAL  MEDICAL  JOURNAL  5/12
Drug Absorption Age Dependance 0 0,25 0,5 0,75 1           CA  27  YEARS  OLD *  Based  on  official  data  from  US  departament’s  of  health  and  human  services  yearly  reports
Subtitle  line Cycle of disease treatment SOURCE  A SOURCE  B SOURCE  C LOREM  IPSUM  DOLOR  SIT  AMET,   CONSECTETUR  ADIPISCING  ELIT LOREM  IPSUM  DOLOR  SIT  AMET,   CONSECTETUR  ADIPISCING  ELIT LOREM  IPSUM  DOLOR  SIT  AMET,   CONSECTETUR  ADIPISCING  ELIT SOURCE  C LOREM  IPSUM  DOLOR  SIT  AMET,   CONSECTETUR  ADIPISCING  ELIT SOURCE  A SOURCE  B LOREM  IPSUM  DOLOR  SIT  AMET,   CONSECTETUR  ADIPISCING  ELIT LOREM  IPSUM  DOLOR  SIT  AMET,   CONSECTETUR  ADIPISCING  ELIT
Subtitle  text Disease diagnosis Healing  method   descripZon  text Diabetes type A Symptom  1 Symptom  2 Symptom  3 Symptom  4 Symptom  5
Influence  of  regular  sport  activity   on  developing  foot  ulcer  amongst   people  with  diabetes  type  A. Method’s effects * LOW  ACTIVITY 84% 16% HIGH  ACTIVITY 60% 40% PATIENTS  WITH  FOOT  ULCER PATIENTS  WITH  HEALTHY  FEET *  Based  on  official  data  from  US  department’s  of  health  and  human  services  yearly  reports
Method  effectiveness  in  numbers Method’s effects 2001 2015 33 87 4 No  of  clinics  that   accomodated  the  method Patients  with  treatment   time  exceeding  one  year Terminal  cases  count 16 123 28
Partners W E ’ D   B E   N O W H E R E   W I T H O U T   T H E M COMPANY’S  NAME COMPANY’S  NAME COMPANY’S  NAME COMPANY’S  NAME COMPANY’S  NAME COMPANY’S  NAME
Meet Michael Kowalsky C A S E   S T U DY   O F   O N E   O F   O U R   PAT I E N T S Michael Kowalsky 28 years old Diabetes Type A NAME AGE DIAGNOSIS NOTES Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nos- trud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem  ipsum  dolor  est. Our Latest Publication
Solution: app L O R E M   I P S U M   D O L O R   S I T   A M E T     Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Number  of  cases  of  disease  by  region Progress 1980 2013 164 11656 88 68 84 WEST  COAST MIDWEST EAST  COAST
Mentions W H AT   D O   T H E   S O U R C E S   S AY ? Publication Title Author,  Year Publication Title Author,  Year Publication Title Author,  Year
References L O R E M   I P S U M   D O L O R E S 1. Author Name, Another Name, 2. Author Name, Another Name, 3. Author Name, 4. Author Name, 5. Author Name, 6. Author Name, 7. Author Name, Author Name, 8. Author Name, Author Name, ArZcle  Title.  Journal  Name  vol.  no.,  pages  (year). Book  Title  (publisher  name,  publisher  locaZon,  year),  pages. Book  Title  (publisher  name,  publisher  locaZon,  year),  pages. ”Technical  Report    Title”  (report  id,  publisher,  locaZon,  year). ”Technical  Report    Title”  (report  id,  publisher,  locaZon,  year). paper  presented  at  the  Conference  Name,  LocaZon,  date paper  presented  at  the  Conference  Name,  LocaZon,  date ArZcle  Title.  Journal  Name  vol.  no.,  pages  (year).

More Related Content

Medical Presentation Template

  • 1. Medical Presentation Template Deck Multiline,  sophisticated   subtitle  text Q.  RALL   SYDNEY,  14  FEBRUARY  2015
  • 2. Agenda C L I C K   T O   A D D   S U B T I T L E 1 2 3 4 5 Introduction Anatomical knowledge behind the discovery Our method compared to others available Pros and cons of using the newest drug Q&A session
  • 3. Multiline  chapter   subtitle  text Part One: Introduction
  • 4. Contact Information B E   S U R E   T O   C O N TA C T   U S   I N   C A S E   O F   A N Y   D O U B T S I. Q. Rall i.q.rall@yahoo.com +1 415 599 2671 228 West 47th Street New York City NY 10036
  • 5. And,  if  we  know  how  to  do  this,  why  isn’t  everybody   doing  it  already? How to prevent the disease?
  • 7. Disease Causes FA C T O R S   T H AT   L E A D   T O   I N C R E A S E D   S U S C E P T I B I L I T Y Diabetes type A First cause of the disease Second cause of the disease Third cause of the disease Fourth cause of the disease
  • 8. Drug characteristics L O R E M   I P S U M   D O L O R   S I T   A M E T ONLY  NATURAL   COMPONENTS IMMEDIATE   ACTION SUITABLE   FOR  CHILDREN LONG  LASTING   EFFECTS
  • 9. Disease Symptoms FA C T O R S   T H AT   L E A D   T O   I N C R E A S E D   S U S C E P T I B I L I T Y Diabetes type A Diabetes type A First cause of the disease Second cause of the disease Third cause of the disease Fourth cause of the disease
  • 10. Summary L O R E M   I P S U M   D O L O R   S I T   A M E T Summary bullet Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit. Summary bullet Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit. Summary bullet Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit. Summary bullet Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit.
  • 11. Milestones M A J O R   E V E N T S   I N   L I F E T I M E   O F   T H E   P R O J E C T Birth of Initial Idea JANUARY  2011 Milestone Name APRIL  2013 Milestone Name DECEMBER  2013 Milestone Name NOVEMBER  2014 Product Ready for Market FEBRUARY  2015 Lorem  ipsum   dolor  sit  amet,   consectetur   adipiscing  elit. Lorem  ipsum   dolor  sit  amet,   consectetur   adipiscing  elit. Lorem  ipsum   dolor  sit  amet,   consectetur   adipiscing  elit. Lorem  ipsum   dolor  sit  amet,   consectetur   adipiscing  elit. Lorem  ipsum   dolor  sit  amet,   consectetur   adipiscing  elit.
  • 12. The Procedure S T E P -­‐ B Y-­‐ S T E P   I N S T R U C T I O N S I II III IV Lorem  ipsum   dolor  sit  amet,   consectetur   adipiscing  elit. Lorem  ipsum   dolor  sit  amet,   consectetur   adipiscing  elit. Lorem  ipsum   dolor  sit  amet,   consectetur   adipiscing  elit. Lorem  ipsum   dolor  sit  amet,   consectetur   adipiscing  elit.
  • 13. Disease phases First phase DescripZon  of  the  phase.  Lorem  ipsum  dolor  sit  amet.I Second phase DescripZon  of  the  phase.  Lorem  ipsum  dolor  sit  amet.II Third phase DescripZon  of  the  phase.  Lorem  ipsum  dolor  sit  amet.III Fourth phase DescripZon  of  the  phase.  Lorem  ipsum  dolor  sit  amet.IV Fifth phase DescripZon  of  the  phase.  Lorem  ipsum  dolor  sit  amet.V
  • 14. Drug specification L O R E M   I P S U M   D O L O R E S 15ML   VOLUME 30MG/S   FLOW  RATE 0.20MM   PARTICLE  SIZE 30MIN   ONSET  OF  ACTION
  • 15. Subtitle  line The Team Behind the Discovery John Doe Head  of  the   department Jane Doe Chief  of   research John Doe Researcher Lab  worker John Doe
  • 16. “This great idea has completely changed my life. I highly recommend this new approach.” ANDY “This great idea has completely changed my life. I highly recommend this new approach.” REBECCA “This great idea has completely changed my life. I highly recommend this new approach.” JOHN
  • 17. Drug Taking Instructions I M P O R TA N T   P O I N T E R S Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit. Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit. Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit. Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit. Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit.
  • 18. Categories C L I C K   T O   A D D   S U B T I T L E Category A Category B Category C Lorem  ipsum  dolor  sit  amet,  consectetur     adipiscing  elit,  sed  do  eiusmod  tempor     incididunt  ut  labore  et  dolore  magna  aliqua. Lorem  ipsum  dolor  sit  amet,  consectetur     adipiscing  elit,  sed  do  eiusmod  tempor     incididunt  ut  labore  et  dolore  magna  aliqua. Lorem  ipsum  dolor  sit  amet,  consectetur     adipiscing  elit,  sed  do  eiusmod  tempor     incididunt  ut  labore  et  dolore  magna  aliqua.
  • 19. Subtitle  line Drugs comparison Drug A Drug B SALICYLIC  ACID IBUPROFENACTIVE  INGREDIENT RISK  OF  COMPLICATIONS16% 40% AMOUNT 200MG325MG
  • 20. Method Comparison CRITERION  ONE CRITERION  ONE CRITERION  ONE CRITERION  ONE CRITERION  ONE Method A Method B Method C
  • 21. Prescription Drug Analysis PROSCONS Sed  do  eiusmod  tempor  incididunt Lorem  ipsum  dolor  sit  amet Consectetur  adipiscing  elit Sed  do  eiusmod  tempor  incididunt Ut  labore  et  dolore  magna  aliqua Ut  enim Consectetur  adipiscing  elit Lorem  ipsum  dolor  sit  amet Ut  labore  et  dolore  magna  aliqua Ut  enim
  • 22. Summary of Expenses L O R E M   I P S U M   D O L O R E S TESTS APPOINTMENTS MISCELLANEOUS TEA  AND  COFFEE TOTAL 2000  $ 7000  $ 2500  $ 500  $ 12  000  $
  • 23. Left Side of Bony Pelvis A S   D E S C R I B E D   I N   P R O F E S S I O N A L   L I T E R AT U R E Lorem  ipsum  dolor  sit  amet,  consectetur     adipiscing  elit,  sed  do  eiusmod  tempor     incididunt  ut  labore  et  dolore  magna   aliqua.  Ut  enim.  Lorem  ipsum  dolor  sit     amet,  consectetur  adipiscing  elit.
  • 24. Left Side of Bony Pelvis - main issues A S   D E S C R I B E D   I N   P R O F E S S I O N A L   L I T E R AT U R E Top corner fraction Lorem  ipsum  dolor  sit  amet,  consectetur     adipiscing  elit,  sed  do  eiusmod  tempor     incididunt  ut  labore  et  dolore  magna  aliqua.     Ut  enim. Bottom end something Lorem  ipsum  dolor  sit  amet,  consectetur     adipiscing  elit,  sed  do  eiusmod  tempor     incididunt  ut  labore  et  dolore  magna  aliqua.     Ut  enim. 1 2 2 1
  • 25. Additional  description  text   concerning  the  problem Challenges we’re facing Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit,   sed  do  eiusmod  tempor   incididunt  ut  labore  et   dolore  magna  aliqua. 1. Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit,   sed  do  eiusmod  tempor   incididunt  ut  labore  et   dolore  magna  aliqua. 2. Lorem  ipsum  dolor  sit  amet,   consectetur  adipiscing  elit,   sed  do  eiusmod  tempor   incididunt  ut  labore  et   dolore  magna  aliqua. 3.
  • 26. Click to add Title C L I C K   T O   A D D   S U B T I T L E The art of medicine consists in amusing the patient while nature cures the disease. —    VOLTAIRE
  • 27. Click to add Title C L I C K   T O   A D D   S U B T I T L E Disease name —  SOURCE,  YEAR,  ADDITIONAL  INFO Dictionary definition of this particular disease. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
  • 28. Lorem  ipsum  dolor  sit  amet,  consec-­‐  tetur  adipiscingelit,  seddo  eiusmod  tempor  incididuntutlabore. million people with diabetes 381
  • 29. Multiple Pie Charts L O R E M   I P S U M   D O L O R E S LOREM  IPSUM   DOLOR  SIT   AMET 84% 16% LOREM  IPSUM   DOLOR  SIT   AMET60% 40% LOREM  IPSUM   DOLOR  SIT   AMET 84% 16% LOREM  IPSUM   DOLOR  SIT   AMET60% 40% LOREM  IPSUM   DOLOR  SIT   AMET 84% 16% LOREM  IPSUM   DOLOR  SIT   AMET60% 40% PATIENTS  WITH    FOOT  ULCER PATIENTS  WITH  HEALTHY  FEET
  • 30. Click to add Title C L I C K   T O   A D D   S U B T I T L E over of  world’s  population   is  predicted  to  be  sick   by  2020 45%
  • 31. Drug Reception C O R R E L AT I O N   B E T W E E N   D R U G   D O S A G E   A N D   S E V E R A L   I N D I C AT O R S           SOURCE:  INTERNATIONAL  MEDICAL  JOURNAL  5/12 DRUG  DOSE CHEMICAL  ACTIVITIY 1 2 3 Second indicator 1 2 First indicator 3 Third indicator
  • 32. Drug Reception C O R R E L AT I O N   B E T W E E N   D R U G   D O S A G E   A N D   I T S   C H E M I C A L   A C T I V I T Y           DRUG  DOSE CHEMICAL  ACTIVITIY Observation Lorem  ipsum  dolor  sit  amet,  consectetur. Observation Lorem  ipsum  dolor  sit  amet,  consectetur. Observation Lorem  ipsum  dolor  sit  amet,  consectetur.
  • 33. Disease Stadia L O R E M   I P S U M   D O L O R E S Lorem  ipsum  dolor           sit  amet,  consectetur   adipiscing  elit,  sed   do  eiusmod  tempor   inci-­‐  didunt  ut  labore   et  dolore  magna   aliqua.  Ut  enim  ad   minim  veniam,  quis   nostrud First Stadium Second Stadium Third Stadium Fourth Stadium Lorem  ipsum  dolor           sit  amet,  consectetur   adipiscing  elit,  sed   do  eiusmod  tempor   inci-­‐  didunt  ut  labore   et  dolore  magna   aliqua.  Ut  enim  ad   minim  veniam,  quis   nostrud Lorem  ipsum  dolor           sit  amet,  consectetur   adipiscing  elit,  sed   do  eiusmod  tempor   inci-­‐  didunt  ut  labore   et  dolore  magna   aliqua.  Ut  enim  ad   minim  veniam,  quis   nostrud Lorem  ipsum  dolor           sit  amet,  consectetur   adipiscing  elit,  sed   do  eiusmod  tempor   inci-­‐  didunt  ut  labore   et  dolore  magna   aliqua.  Ut  enim  ad   minim  veniam,  quis   nostrud DAY    0 AFTER  A  WEEK FIRST  MONTH AFTER  A  YEAR
  • 34. Sources  of  financing Finances 44% 40% 16% SOURCE  A SOURCE  B SOURCE  C LOREM  IPSUM  DOLOR  SIT  AMET,   CONSECTETUR  ADIPISCING  ELIT LOREM  IPSUM  DOLOR  SIT  AMET,   CONSECTETUR  ADIPISCING  ELIT LOREM  IPSUM  DOLOR  SIT  AMET,   CONSECTETUR  ADIPISCING  ELIT
  • 35. Officially reported cases L O R E M   I P S U M   D O L O R E S 0 125 250 375 500 1985 1990 1995 2000 2005 2010 2015 110 199 280 395 297 378 460 SOURCE:  INTERNATIONAL  MEDICAL  JOURNAL  5/12
  • 36. Drug Absorption Age Dependance 0 0,25 0,5 0,75 1           CA  27  YEARS  OLD *  Based  on  official  data  from  US  departament’s  of  health  and  human  services  yearly  reports
  • 37. Subtitle  line Cycle of disease treatment SOURCE  A SOURCE  B SOURCE  C LOREM  IPSUM  DOLOR  SIT  AMET,   CONSECTETUR  ADIPISCING  ELIT LOREM  IPSUM  DOLOR  SIT  AMET,   CONSECTETUR  ADIPISCING  ELIT LOREM  IPSUM  DOLOR  SIT  AMET,   CONSECTETUR  ADIPISCING  ELIT SOURCE  C LOREM  IPSUM  DOLOR  SIT  AMET,   CONSECTETUR  ADIPISCING  ELIT SOURCE  A SOURCE  B LOREM  IPSUM  DOLOR  SIT  AMET,   CONSECTETUR  ADIPISCING  ELIT LOREM  IPSUM  DOLOR  SIT  AMET,   CONSECTETUR  ADIPISCING  ELIT
  • 38. Subtitle  text Disease diagnosis Healing  method   descripZon  text Diabetes type A Symptom  1 Symptom  2 Symptom  3 Symptom  4 Symptom  5
  • 39. Influence  of  regular  sport  activity   on  developing  foot  ulcer  amongst   people  with  diabetes  type  A. Method’s effects * LOW  ACTIVITY 84% 16% HIGH  ACTIVITY 60% 40% PATIENTS  WITH  FOOT  ULCER PATIENTS  WITH  HEALTHY  FEET *  Based  on  official  data  from  US  department’s  of  health  and  human  services  yearly  reports
  • 40. Method  effectiveness  in  numbers Method’s effects 2001 2015 33 87 4 No  of  clinics  that   accomodated  the  method Patients  with  treatment   time  exceeding  one  year Terminal  cases  count 16 123 28
  • 41. Partners W E ’ D   B E   N O W H E R E   W I T H O U T   T H E M COMPANY’S  NAME COMPANY’S  NAME COMPANY’S  NAME COMPANY’S  NAME COMPANY’S  NAME COMPANY’S  NAME
  • 42. Meet Michael Kowalsky C A S E   S T U DY   O F   O N E   O F   O U R   PAT I E N T S Michael Kowalsky 28 years old Diabetes Type A NAME AGE DIAGNOSIS NOTES Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nos- trud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
  • 43. Lorem  ipsum  dolor  est. Our Latest Publication
  • 44. Solution: app L O R E M   I P S U M   D O L O R   S I T   A M E T     Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
  • 45. Number  of  cases  of  disease  by  region Progress 1980 2013 164 11656 88 68 84 WEST  COAST MIDWEST EAST  COAST
  • 46. Mentions W H AT   D O   T H E   S O U R C E S   S AY ? Publication Title Author,  Year Publication Title Author,  Year Publication Title Author,  Year
  • 47. References L O R E M   I P S U M   D O L O R E S 1. Author Name, Another Name, 2. Author Name, Another Name, 3. Author Name, 4. Author Name, 5. Author Name, 6. Author Name, 7. Author Name, Author Name, 8. Author Name, Author Name, ArZcle  Title.  Journal  Name  vol.  no.,  pages  (year). Book  Title  (publisher  name,  publisher  locaZon,  year),  pages. Book  Title  (publisher  name,  publisher  locaZon,  year),  pages. ”Technical  Report    Title”  (report  id,  publisher,  locaZon,  year). ”Technical  Report    Title”  (report  id,  publisher,  locaZon,  year). paper  presented  at  the  Conference  Name,  LocaZon,  date paper  presented  at  the  Conference  Name,  LocaZon,  date ArZcle  Title.  Journal  Name  vol.  no.,  pages  (year).